Because people that carry the APOE e4 gene variant surface to possess a better risk of great difficulties, the FDA endorses being tested for the gene variant before beginning treatment with lecanemab or donanemab. But there is not any one final result. Signs or symptoms could continue being secure For https://kabirt642nxg1.blogars.com/33285278/the-definitive-guide-to-cognitive-tests-for-dementia